Andrew Craig Miller

This profile gathers the share dealings of Andrew Craig Miller across 2 companies, led by Karuna Therapeutics, Inc. and Kyverna Therapeutics, Inc. Over a trading history stretching from 2 March 2020 to 24 February 2026, the count stands at 55 filings.

Sales make up the whole of the open-market record (21 sales, €13.2M). Outside the open market, there are 3 share grants and 30 option exercises.

The latest filing, published on 4 March 2026, reports a share grant in Kyverna Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.